Mechanisms of action of currently used antiseizure drugs

GJ Sills, MA Rogawski - Neuropharmacology, 2020 - Elsevier
Antiseizure drugs (ASDs) prevent the occurrence of seizures; there is no evidence that they
have disease-modifying properties. In the more than 160 years that orally administered …

Hippocampal GABAergic inhibitory interneurons

KA Pelkey, R Chittajallu, MT Craig… - Physiological …, 2017 - journals.physiology.org
In the hippocampus GABAergic local circuit inhibitory interneurons represent only~ 10–15%
of the total neuronal population; however, their remarkable anatomical and physiological …

Transcriptional architecture of synaptic communication delineates GABAergic neuron identity

A Paul, M Crow, R Raudales, M He, J Gillis, ZJ Huang - Cell, 2017 - cell.com
Understanding the organizational logic of neural circuits requires deciphering the biological
basis of neuronal diversity and identity, but there is no consensus on how neuron types …

Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial

S Kanes, H Colquhoun, H Gunduz-Bruce, S Raines… - The Lancet, 2017 - thelancet.com
Background Post-partum depression is a serious mood disorder in women that might be
triggered by peripartum fluctuations in reproductive hormones. This phase 2 study …

Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder

AJ Cutler, GW Mattingly, V Maletic - Translational Psychiatry, 2023 - nature.com
The pathophysiology of major depressive disorder (MDD) is thought to result from impaired
connectivity between key brain networks. Gamma-aminobutyric acid (GABA) is the key …

The central amygdala as an integrative hub for anxiety and alcohol use disorders

NW Gilpin, MA Herman, M Roberto - Biological psychiatry, 2015 - Elsevier
The central amygdala (CeA) plays a central role in physiologic and behavioral responses to
fearful stimuli, stressful stimuli, and drug-related stimuli. The CeA receives dense inputs from …

GABAkines–Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors

A Lippa, MM Poe, JL Smith, X Jin, X Ping… - Pharmacology & …, 2022 - Elsevier
Positive allosteric modulators of γ-aminobutyric acid-A (GABA A) receptors or GABAkines
have been widely used medicines for over 70 years for anxiety, epilepsy, sleep, and other …

The GABAA receptor as a therapeutic target for neurodevelopmental disorders

S Braat, RF Kooy - Neuron, 2015 - cell.com
Intellectual disability, autism spectrum disorder, and epilepsy are prime examples of
neurodevelopmental disorders that collectively affect a significant percentage of the world …

Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors

M Schumacher, C Mattern, A Ghoumari… - Progress in …, 2014 - Elsevier
Progesterone is commonly considered as a female reproductive hormone and is well-known
for its role in pregnancy. It is less well appreciated that progesterone and its metabolite …

[HTML][HTML] Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator

AL Althaus, MA Ackley, GM Belfort, SM Gee, J Dai… - …, 2020 - Elsevier
Abstract Zuranolone (SAGE-217) is a novel, synthetic, clinical stage neuroactive steroid
GABA A receptor positive allosteric modulator designed with the pharmacokinetic properties …